Oleg Khaykin’s recent SEC Form 4 activity reveals a pronounced selling bias, concentrated almost exclusively in Viavi Solutions (VIAV). Over the trailing twelve months, he has executed 17 open-market sales totaling approximately $36 million, with zero open-market purchases recorded across any holding. The selling cadence has been aggressive and consistent, punctuated by a cluster of large dispositions in early May 2026. Between May 5 and May 8 alone, Khaykin offloaded VIAV shares in five separate transactions worth roughly $20.8 million, including a single-day sale of $7.08 million on May 8. This followed a similarly heavy February 2026 stretch, where seven sales between February 4 and February 10 generated about $9.2 million in proceeds.
The pattern is not one of gradual trimming but of repeated, sizable block sales. December 2025 saw five VIAV sales totaling roughly $3.2 million, and the selling has continued into the current quarter. Notably, all of Khaykin’s VIAV transactions are coded as open-market sales ("S"), which represent discretionary decisions to liquidate, rather than automatic or tax-driven events. In contrast, his activity in Avnet (AVT) consists entirely of "A" codes—compensation grants and awards—totaling roughly $93,000 in value, with no corresponding sales. This bifurcation is telling: he is accumulating AVT only through equity compensation while systematically reducing his VIAV position through voluntary market sales.
The absence of any "P" (purchase) codes across his entire filing history underscores a one-directional posture. While the AVT grants are non-discretionary and reflect corporate compensation cycles, the VIAV sales are the only signal of active portfolio management. With no buys to offset the $36 million in sales, Khaykin’s recent behavior demonstrates a clear net reduction in his exposure to Viavi, a trend that has accelerated in the most recent reporting period.
AI-assisted summary